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Purpose: To evaluate the technical feasibility and oncologic safety, we assessed the short-term and long-term outcomes of laparoscopic 
resection of the small bowel gastrointestinal stromal tumors smaller than 5 cm by comparing those of open surgery by subgroup analysis 
based on tumor size.
Materials and Methods: From November 1993 to January 2011, 41 laparoscopic resections were performed among the 95 patients 
who underwent resection of small intestine ≤10 cm in diameter. The clinicopathologic features, perioperative outcomes, recurrences 
and survival of these patients were reviewed.
Results: The postoperative morbidity rates were comparable between the 2 groups. Laparoscopic surgery group showed significantly 
shorter operative time (P=0.004) and duration of postoperative hospital stay (P<0.001) than open surgery group and it was more 
apparent in the smaller tumor size group. There were no difference in 5-year survival for the laparoscopic surgery versus open surgery 
groups (P=0.163), and in 5-year recurrence-free survival (P=0.262). The subgroup analysis by 5 cm in tumor size also shows no re-
markable differences in 5-year survival and recurrence-free survival.
Conclusions: Laparoscopic resection for small bowel gastrointestinal stromal tumors of size less than 10 cm has favorable short-term 
postoperative outcomes, while achieving comparable oncologic results compared with open surgery. Thus, laparoscopic approach can 
be recommended as a treatment modality for patients with small bowel gastrointestinal stromal tumors less than 10 cm in diameter.
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Introduction
Gastrointestinal stromal tumors (GISTs) are the most common 
type of subepithelial tumor of the gastrointestinal tract (GI) and 
account for only 0.1% to 0.3% of all GI tumors.(1) After finding 
out that GISTs originate from the interstitial cell of Cajal, an im-
munohistochemical marker CD 117 for the KIT protein enables in 
distinguishing GIST from other subepithelial tumor such as leio-
myoma, leiomyosarcoma and leiomyoblastoma.(2,3) Understanding 
of these disease entities make it possible to apply targeted therapy 
using tyrosine kinase inhibitors for metastatic or inoperable tumors. 
However, surgical resection with a negative margin is the main 
treatment for primary GISTs.(4-6) 
GIST most commonly arises in the stomach and secondarily in 
the small intestine along the digestive tract. There have been only 
a few studies of small intestinal GISTs unlike gastric GISTs and 
some study reports that small intestinal GISTs are more malignant 
than gastric tumors with similar size and mitosis parameters in 
almost all categories.(7,8) In the meantime, laparoscopic resection 
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with a negative gross margin is oncologically justified for gastric 
GISTs smaller than 5 cm.(9-13) However, it still remains unknown 
whether minimally invasive resection of small intestinal GIST is 
technically and oncologically feasible. To the best of our knowl-
edge, there have been no study evaluating both the technical safety 
and oncologic feasibility of laparoscopic resection of performed 
for GISTs of small intestine. The purpose of this study is to evalu-
ate the surgical outcomes following laparoscopic resection of small 
bowel GIST by comparing those following open surgery in terms 
of early postoperative outcomes and long-term oncologic out-
comes. 
Materials and Methods
Between November 1993 and January 2011, 120 patients under-
went surgery for small bowel GISTs at the Department of Surgery, 
Yonsei University Health System, Seoul, Korea. Among them, 8 
patients had coexistence of other malignancies and 17 patients had 
a tumor greater than 10 cm. After excluding those 25 patients, we 
included 95 patients with small bowel GIST for the analyses. There 
were 54 patients who underwent open surgery (OPEN group) while 
the other 41 patients underwent laparoscopic surgery (LAP group). 
For LAP group, complete small bowel exploration and localization 
of tumors were performed laparoscopically, followed by resec-
tion of small bowel and either intracorporeal or extracorporeal 
anastomosis. Small bowel division was performed by linear stapler. 
The specimen was retrieved through the umbilical incision or 
minilaparotomy. Small bowel continuity was recovered by stapled 
side-to-side anastomosis or end-to-end hand sewn anastomosis 
performed extracorporeally, or intracorporeally. 
The clinicopathological characteristics and data obtained for 
each patient included following: age, gender, tumor size, tumor lo-
cation, abdominal operation history, operation type, operation time, 
postoperative complications, duration of postoperative hospital stay, 
recurrence and survival. Tumor risk category was defined by tumor 
size, mitotic index and tumor location, as suggested by Fletcher et 
al.(14) All the operations were performed by a various surgeons and 
surgical technique was selected according to individual surgeon’s 
preference and patient’s consent. Follow-up results were obtained 
from patient’s medical records, and recurrences were detected by 
computed tomography, positron emission tomography, etc. 
1. Statistical analysis
All the statistical analyses were performed using IBM SPSS 
ver. 20.0 for Windows (IBM Co., Armonk, NY, USA). Categorical 
variables were presented in proportions using the chi square tests. 
Continuous variables were presented as mean and standard devia-
tion and Student t-test (parametric distribution) or Mann-Whitney 
test (nonparametric distribution) were used to analyze differences. 
Differences were considered statistically significant at a P-value of 
＜0.05 at the conventional two-tailed alpha level of 0.5. The sur-
vival was calculated on the basis of the interval from surgery to pa-
tient’s death or last time to follow-up. Recurrence-free and overall 
survival rate were estimated using a Kaplan-Meier method. A log-
rank method was used to test the equality of survival distributions 
between the two groups.
Results
The clinical characteristics of the LAP and OPEN groups were 
described in Table 1. The two groups were similar in terms of age, 
gender, tumor location, previous abdominal operation history. 
The median tumor size of surgically resected specimens in OPEN 
group was larger than that in LAP group (P=0.006). The proportion 
Table 1. Clinical characteristics of small bowel GISTs patients 
Variable Open  (n=54) 
Laparoscopy
(n=41) P-value
Age (yr) 58 (24~79) 57 (20~77) 0.651
Gender
   Male
   Female
25 (46.3)
29 (53.7)
21 (51.2)
20 (48.8)
0.634
Age (yr) 58 (24~79) 57 (20~77) 0.651
Tumor location
   Duodenum
   Jejunum, Ileum
 
19 (35.2)
35 (64.8)
 
9 (22.0)
32 (78.0)
0.161
Tumor size (cm) 
   ≤5
   5<size≤10
5.4 (1.3~10.0)
26 (48.1)
28 (68.3)
4.0 (1.5~10.0)
28 (51.9)
13 (31.7)
0.006†  
0.050‡  
Previous abdominal 
  operation history
15 (27.8) 9 (22.0) 0.517
Risk stratification*
   Low
   Intermediate
   High
23 (42.6)
16 (29.6)
15 (27.8)
28 (68.3)
7 (17.1)
6 (14.6)
0.045
Values are presented as median (range) or median (%). GIST = 
gastrointestinal stromal tumor. *Based on modification of the National 
Institutes of Health consensus classification system regarding tumor 
site and tumor rupture, †Student t-test, ‡chi-square test.
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of intermediate and high risk tumors in OPEN group was higher 
than that in LAP (P=0.045).
The surgical outcomes of the two groups are presented in Table 
2. Mean operation time of the LAP group was significantly shorter 
than that of the OPEN group (LAP 111.6 minutes versus OPEN 
169.0 minutes, P=0.005). The statistical difference was noted only 
in the subgroup below 5 cm in diameter (LAP 109.6 minutes ver-
sus OPEN 180.7 minutes, P=0.005). Although operation time of 
LAP group (116.3 minutes) was shorter than that of OPEN (158.2 
minutes) in the subgroup larger than 5 cm, the difference was not 
statistically significant (P=0.241). The median duration of postop-
erative hospital stay for LAP group was shorter than OPEN group 
(LAP 7.1 days versus OPEN 12.4 days, P＜0.001). Operation-
related morbidities were not significantly different between the two 
groups; 8 patients in OPEN group (14.8%) and 5 in the LAP group 
(13.7%). There was one perioperative death in the LAP group, 
related to bleeding secondary to recurrent anastomosis leakages. 
There was one conversion of laparoscopy to open. However, there 
was no episode of tumor rupture or spillage, and no major intraop-
erative complications in both groups. Sixteen patients in the OPEN 
group and three in the LAP group received imatinib treatment, 
respectively. The number of patients with GIST received adjuvant 
Fig. 1. Venn diagram depicting recur-
rence patterns, with number (percent) 
of patients with each category of recur-
rence pattern. OPEN = open surgery; 
LAP = laparoscopic surgery.
Table 2. Operative characteristics and perioperative outcomes
Variable Open (n=54)
Laparoscopy
(n=41) P-value
Operation type
   Wedge resection
   Segmental resection
   Pancreaticoduodenectomy 
   Distal gastrectomy
11 (20.4)
38 (70.4)
4 (7.4)
1 (1.9)
18 (43.9)
23 (56.1)
0 (0)
0 (0)
0.033
Operation time (min)
   ≤5 in tumor size
   5<minutes≤10 in tumor size
169.0±106.3
180.7±105.7 
158.2±107.8
111.6±75.6
109.6±72.1 
116.3±86.3
0.005
0.005
0.241
Postoperative hospital stay (d)
   ≤5
   5<day≤10
12.4±6.2
12.0±4.9
12.8±7.2
7.1±7.8
7.3±9.1
6.9±4.2
<0.001
0.022
0.009
Postoperative mortality 0 (0.0) 1 (2.3)
Postoperative complications 8 (14.8) 5 (13.7) 0.713
Curability
   R0
   R1
   R2
49 (90.7)
0 (0.0)
5 (9.3)
41 (100.0)
0 (0.0)
0 (0.0)
0.045
Values are presented as overall mean (%) or overall mean±standard 
deviation.
Table 3. Adjuvant treatment and oncologic outcomes for 
laparoscopic versus open small bowel GIST resections
Variable Open (n=54)
Laparoscopy
(n=41) P-value
Adjuvant treatment
   None
   Imatinib
38 (70.4)
16 (29.6)
36 (87.8)
5 (12.2)
0.043
Recurrences, metastatis 13 (24.1) 3 (7.3) 0.031
Values are presented as number (%). GIST = gastrointestinal stromal 
tumor.
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treatment and oncologic outcomes between the two groups are 
shown in Table 3.
With a mean follow-up of 24.7 months in the LAP group and 
51.6 months in the OPEN group, tumor recurrence was detected in 
13 cases in the OPEN group and 3 in the LAP group. The sites of 
recurrences are shown in Fig. 1. Hepatic metastasis was the most 
common site of recurrence. As for LAP group, one case was found 
at liver, 1 at mesentery/omentum, and 1 at duodenum. No lymph 
node recurrence was noted in both subgroups. 
There were no significant difference in overall survival for 
the LAP versus OPEN groups (P=0.163), and in recurrence-
free survival (P=0.262). The subgroup analysis by 5 cm in tumor 
size (≤5 and 5＜size≤10) also shows no significant differences in 
overall and recurrence-free survival between two groups (Fig. 2, 3). 
Discussion
We found that laparoscopic resection can be safely performed 
for small intestinal GIST with less than 10 cm in diameter com-
pared with open surgery. Laparoscopic approach showed better 
early postoperative outcomes than open approach in terms of op-
eration time, estimated blood loss, and postoperative hospital stay, 
especially for small intestinal GIST. Besides, laparoscopic resection 
was oncologically comparable to open surgery when it was com-
pared with respect to not only margin status and tumor spillage 
during operation but also recurrence and survival after surgery. 
It has been suggested that large size gastric GIST is not recom-
mended for laparoscopic surgery because of difficulties in ma-
nipulating tumor without tumor cell spillage.(15) Unlike to gastric 
GIST, laparoscopic operative techniques for small intestinal GIST 
are diverse and depending on the location of the small bowel.(16) 
If there is no adjacent organ invasion, small intestinal GIST can be 
manipulated without any direct contact to the mass by grabbing the 
mesentery or nearby normal small bowel segment. With this mo-
bility, most small bowel GIST can be treated by simple segmental 
resection either by intracorporeal or by extracorporeal anastomosis, 
except for duodenal and proximal jejunal GISTs. In most of the 
cases, GISTs are oval shape thus specimen can be delivered through 
a bit smaller incision size than shortest diameter of the mass. Thus, 
even with the mass size in 10 cm in diameter, it can be delivered 
Fig. 2. Kaplan-Meier analysis of (A) overall survival under 10 cm in 
tumor size, (B) below 5 cm and (C) over 5 cm. OPEN = open surgery; 
LAP = laparoscopic surgery.
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through a much small incision. Thus, small intestinal GISTs have 
several appealing characteristics for laparoscopic approach. 
When we are trying to apply laparoscopic approach for small 
intestinal GIST, we have to consider long-term outcomes as well 
as early postoperative results. As small intestinal GIST is regarded 
as having a more aggressive malignant potential than gastric GIST 
has, evaluation of long-term oncological outcomes is essential, 
especially when size of the tumor is large.(17,18) While there have 
been many studies for the oncological safety of LAP group for gas-
tric GIST of larger tumors, studies dealt with long-term outcomes 
after LAP group for small intestinal GIST compared with open 
surgery are rare. Our study adds evidence that laparoscopic applica-
tion for small intestinal GIST can be safely applied. 
However, our study has limitations mainly coming from its 
retrospective nature. Although most baseline characteristics were 
comparable, patients treated by laparoscopy had smaller tumors. 
Thus, we analyzed outcomes after size stratification. There were 
selection bias in selecting operative approaches by the surgeons’ 
preference. Some surgeons have little experience of advanced lapa-
roscopic procedure and some surgeons were expert in LAP group. 
In addition, patients were also biased based on their information for 
the types of surgery, thus the selection of the operation type was 
decided based on their limited knowledge. Other limitation was 
rather long study duration makes it difficult to evaluate the LAP 
group. Relatively more patients of the OPEN group was skewed 
towards early period of study compared to those of the LAP group. 
This may have introduced biases because of the differences in 
mastering operational skills and by rapid development and im-
provement of instruments.
In conclusion, our study demonstrated that laparoscopic ap-
proach can be safely adopted for small intestinal GIST. Laparo-
scopic resection for small bowel GISTs could get favorable short-
term postoperative outcomes while achieving comparable oncologic 
results compared with open surgery. Thus, laparoscopic approach 
can be regarded as an recommendable treatment modality for pa-
tients with small bowel GISTs less than 10 cm in diameter.
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